CryoCell International Company Leadership

CryoCell International Management Team Effectiveness

The company has return on total asset (ROA) of 0.0429 % which means that it generated a profit of $0.0429 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 1.292 %, meaning that it created $1.292 on every $100 dollars invested by stockholders. CryoCell International's management efficiency ratios could be used to measure how well CryoCell International manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CryoCell International's Return On Tangible Assets are quite stable compared to the past year. Return On Capital Employed is expected to rise to 0.08 this year, although the value of Return On Equity will most likely fall to (0.04). At this time, CryoCell International's Return On Tangible Assets are quite stable compared to the past year. Return On Assets is expected to rise to 0.01 this year, although the value of Other Current Assets will most likely fall to about 1.1 M. Common Stock Shares Outstanding is expected to rise to about 7.8 M this year, although the value of Net Income Applicable To Common Shares will most likely fall to about 2.1 M. The market capitalization of CryoCell International is $27.63 Million. CryoCell International retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run. Some institutional investors establish a significant position in stocks such as CryoCell International in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of CryoCell International, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

CryoCell International Workforce Comparison

CryoCell International Profit Margins

The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.24 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.24.

CryoCell International Insider Trading History

CryoCell International Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as CryoCell International often depends on how effective the management is. CryoCell International management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CryoCell management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CryoCell management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. Projected growth potential of CryoCell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CryoCell International assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Investors evaluate CryoCell International using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CryoCell International's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause CryoCell International's market price to deviate significantly from intrinsic value.

It's important to distinguish between CryoCell International's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CryoCell International should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CryoCell International's market price signifies the transaction level at which participants voluntarily complete trades.